Evidence map›Paper›PMID 28207898›Full record

ArticlePloS one2017

Distinct susceptibility and applicability of MDCK derivatives for influenza virus research.

Shih-Chao Lin, Matthew A Kappes, Mei-Chun Chen, Chi-Chen Lin, Tony T Wang

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
3.3field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 36 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. In Vitro Anti-Influenza Virus Activity of Non-PolarPharmaceuticals (Basel, Switzerland) · 2022
    Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Entry ofPathogens (Basel, Switzerland) · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Shih-Chao LinProgram in Medical Biotechnology, National Chung Hsing University, Taichung, Taiwan.
Matthew A KappesCenter for Infectious Diseases, SRI International, Harrisonburg, Virginia, United States of America.
Mei-Chun ChenCenter for Infectious Diseases, SRI International, Harrisonburg, Virginia, United States of America.
Chi-Chen LinDepartment of Biomedical Sciences, National Chung Hsing University, Taichung, Taiwan.
Tony T WangCenter for Infectious Diseases, SRI International, Harrisonburg, Virginia, United States of America.
SRI International · USChina Medical University Hospital · TW

Funding

Tight Junction: Gate to HCV Tropism, Therapeutics and PathogenesisR01DK088787 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI STEIN, PAUL L · 2010 to 2019
$4.2M
NIDDK NIH HHS R01 DK088787
6 · The paper itself

Abstract

Madin-Darby Canine Kidney (MDCK) cells are widely utilized as a substrate for influenza virus isolation and propagation due to the high yields of virus. Here we compared the conventional MDCK cell line, MDCK-SIAT1 and MDCK-London for viral production, cell survival, and suitability in testing antivirals using six influenza strains including two H1N1 (pandemic and epidemic strains), three H3N2 and one influenza B strain. Overall our results suggest that MDCK-London cell line is superior for virus culturing and quantification, and hence an ideal platform to evaluate antiviral drug efficacy against multiple strains of influenza. Our data also suggests that while virus titers determined by the hemagglutination assay (HA) and neuraminidase activity (NA) are widely used to indicate viral load, there is a poor correlation between these measurements and the infectious titer obtained by plaque assay.

Indexed as

Hemagglutination, ViralAnimalsCells, CulturedDogsHemagglutination TestsInfluenza A virusMadin Darby Canine Kidney CellsOrthomyxoviridae Infections

Identifiers

PMID28207898
PMCPMC5313193
OpenAlexW2587805155

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.